About

Dr. Marc E. Goldschmidt, MD, is a Clinical Assistant Professor in Medicine at Stony Brook University. His specialty is in Cardiology, with a focus on Heart Failure and Transplantation Cardiology. He has completed fellowships at Columbia University College of Physicians and Surgeons in 2003 and at Emory University School of Medicine in 2002, specializing in Internal Medicine and Cardiology. Dr. Goldschmidt earned his medical degree from Albert Einstein College of Medicine of Yeshiva University in 1994 and completed his residency at the University of Washington School of Medicine in 1997. He is board certified in Advanced Heart Failure and Transplant Cardiology by the American Board of Internal Medicine since 2012. His professional practice includes locations at Stony Brook and Hampton Bays, where he provides specialized cardiology care.

Research topics

• Cardiology
• Medicine
• Internal medicine
• Intensive care medicine
• Chemistry
• Chromatography
• Radiology

Selected publications

• Point of Care Ultrasound (POCUS) in the Management of Heart Failure: A Narrative Review

  Journal of Personalized Medicine · 2024 · 14 citations

  • Medicine
  • Cardiology
  • Radiology

  Assessing for volume overload is a key component of both short and long-term management of heart failure patients. Physical examination findings are neither sensitive nor specific for detecting congestion, and subclinical congestion may not be evident at the time of examination. Point of care ultrasound (POCUS) is an efficient and non-invasive way to assess heart failure patients for volume overload. The aim of our narrative review is to summarize how each of the following ultrasound modalities can be used to assess for congestion in the heart failure population: 2D and Doppler echocardiography, lung ultrasound, inferior vena cava ultrasound, internal jugular vein ultrasound, and venous excess grading. While each of these modalities has their limitations, their use in the acute and outpatient space offers the potential to reduce heart failure readmissions and mortality.

  PublisherOA PDFDOI

• Sacubitril/Valsartan and Cognitive Outcomes in Heart Failure With Reduced Ejection Fraction

  JACC Advances · 2023 · 20 citations

  • Internal medicine
  • Cardiology
  • Medicine

  Background: Recent trial data refute concerns about neurocognitive off-target effects of neprilysin inhibition with sacubitril and suggest benefit in patients with heart failure and ejection fraction >40%. We hypothesized that sacubitril/valsartan is associated with improved cognitive outcomes in patients with heart failure and reduced ejection fraction (HFrEF). Objectives: The purpose of this study was to compare 3-year cognitive outcomes in patients with HFrEF who receive sacubitril/valsartan vs angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs). Methods: Retrospective cohort study of: 1) 11,313 adults with HFrEF (International Classification of Diseases-10th Revision-Clinical Modification [ICD-10-CM] codes: I50.2 or I50.4) started on sacubitril/valsartan between 1/1/2015 and 12/31/2019; and 2) 11,313 propensity matched patients receiving ACEI/ARB during that time. Data were obtained from the TriNetX Research Network, encompassing 41 health care organizations in the United States. Primary endpoint was the composite of cognitive decline (ICD-10-CM: R41.8), dementia (ICD-10-CM: F01-F03), and Alzheimer's disease (ICD-10-CM: G30). Results: < 0.001). Conclusions: Sacubitril/valsartan was associated with lower 3-year rates of neurocognitive disorders when compared to ACEI/ARBs in patients with HFrEF.

  PublisherDOI

• Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options

  Heart Failure Reviews · 2023 · 78 citations

  • Medicine
  • Cardiology
  • Internal medicine
  DOI

Recent grants

• NIH Grant F32HL010104

  NIH · $75k

Frequent coauthors

• Laura Adams

  9 shared

• Kathy Wolski

  Cleveland Clinic

  9 shared

• A Martin

  9 shared

• Leslie Mele

  Cleveland Clinic

  9 shared

• S. Pardi

  Newark Beth Israel Medical Center

  9 shared

• J. Prevost-Fernandez

  Westchester Medical Center

  9 shared

• M. Camacho

  9 shared

• V. Hou

  Newark Beth Israel Medical Center

  9 shared

Education

• M.D., Medicine

  Stony Brook University School of Medicine

  1990

• B.S., Biology

  University of California, San Diego

  1986

Similar researchers at Stony Brook University

• Scott McLennanh-145
• Anatoly I. Frenkelh-101
• Vitaly Citovskyh-98
• Michael R. Douglash-91
• Minghua Zhangh-89